Literature DB >> 6717122

Care of patients with colorectal cancer. A comparison of a health maintenance organization and fee-for-service practices.

A M Francis, L Polissar, A B Lorenz.   

Abstract

The presence of a population-based cancer registry in a community with a health maintenance organization (HMO) enabled a detailed, longitudinal comparison to be made of care given for colorectal cancer in an HMO with traditional fee-for-services (FFS) care. An interview survey of 39 HMO and 150 FFS patients was supplemented with data from the cancer registry. Patients seen by the two provider groups were similar with respect to sociodemographic characteristics, severity of disease at diagnosis, and concurrent medical conditions. The HMO patients received more prediagnostic care but did not receive definitive surgical treatment as quickly as the FFS group. There were few differences in care, however, once diagnosis was made; there were no differences in access to care, rates of definitive surgery, chemotherapy, radiation therapy, length of hospitalization, number of follow-up physician visits, and most measures of satisfaction with care. No differences in outcome, including 4-year survival and 1-year health status, were found. HMO patients expressed significantly less concern about the cost of their care. These findings suggest an initial hesitancy to provide definitive care by the HMO but no significant differences in either the process or outcome of care once definitive care is begun.

Entities:  

Mesh:

Year:  1984        PMID: 6717122     DOI: 10.1097/00005650-198405000-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  15 in total

1.  Enrollee health status under Medicare risk contracts: an analysis of mortality rates.

Authors:  G Riley; J Lubitz; E Rabey
Journal:  Health Serv Res       Date:  1991-06       Impact factor: 3.402

2.  Management of colorectal cancer in Medicare health maintenance organizations.

Authors:  S M Retchin; B Brown
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

3.  Comments on HCFA hospital death rate statistical outliers. Health Care Financing Administration.

Authors:  M S Blumberg
Journal:  Health Serv Res       Date:  1987-02       Impact factor: 3.402

4.  A longitudinal study of hospitalization rates for patients with chronic disease: results from the Medical Outcomes Study.

Authors:  E C Nelson; C A McHorney; W G Manning; W H Rogers; M Zubkoff; S Greenfield; J E Ware; A R Tarlov
Journal:  Health Serv Res       Date:  1998-02       Impact factor: 3.402

Review 5.  HSOs: Ontario's answer to HMOs?

Authors:  D J Weinkauf; H E Scully
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

6.  Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

Authors:  Polina Khrizman; Joyce C Niland; Anna ter Veer; Dana Milne; Kelli Bullard Dunn; William E Carson; Paul F Engstrom; Stephen Shibata; John M Skibber; Martin R Weiser; Deborah Schrag; Al B Benson
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

7.  Effects of health insurance and race on colorectal cancer treatments and outcomes.

Authors:  R G Roetzheim; N Pal; E C Gonzalez; J M Ferrante; D J Van Durme; J P Krischer
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

8.  The impact of membership in a health maintenance organization on hospital admission rates for acute chest pain.

Authors:  S D Pearson; T H Lee; E Lindsey; T Hawkins; E F Cook; L Goldman
Journal:  Health Serv Res       Date:  1994-04       Impact factor: 3.402

9.  Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees.

Authors:  G F Riley; A L Potosky; J D Lubitz; M L Brown
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

10.  Satisfaction with ambulatory care of persons with AIDS: predictors of patient ratings of quality.

Authors:  V E Stone; J S Weissman; P D Cleary
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.